EUVIMEDEUVIMED entdecken
Crossref

MicroRNA hsa‐let‐7e‐5p in hUC ‐ MSC ‐ EVs alleviates oral mucositis by targeting TAB2

Shuting Lin, Dong Lai, Yan Tian, Fei Lai, Min Long, Changfu Ji, Gengxin Hao iD

Scandinavian Journal of Immunology · 2024

DOI: 10.1111/sji.13399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Shuting Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion, Central Laboratory, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China. Hauptthemen laut MEDLINE: MicroRNAs, Stomatitis, Adaptor Proteins, Signal Transducing, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral mucositis (OM) is a severe side effect of anti‐cancer therapy, with limited available treatments. Mesenchymal stem cells (MSCs) and their secreted extracellular vesicles (EVs) have demonstrated effective protection against OM. However, the underlying mechanism remains elusive. In the current study, we purified EVs secreted by human umbilical cord MSCs (hUC‐MSC‐EVs) and investigated their role in lipopolysaccharide (LPS)‐induced human oral keratinocytes (HOKs). We observed that treatment with hUC‐MSC‐EVs significantly reduced the inflammatory response of HOKs to LPS induction. Through small RNA‐seq using miRNAs extracted from hUC‐MSC‐EVs, we identified hsa‐let‐7e‐5p as one of the most highly expressed miRNAs. Bioinformatic analysis data indicated that hsa‐let‐7e‐5p may inhibit the NF‐κB signalling pathway by targeting TAB2. Overexpression of the hsa‐let‐7e‐5p inhibitor significantly attenuated the anti‐inflammatory effect of hUC‐MSC‐EVs in LPS‐induced HOKs, which could be reversed by the knockdown of TAB2. In addition, we administered hUC‐MSC‐EVs in a hamster model for OM and observed that these EVs alleviated OM phenotypes. Taken together, our observations suggest that hsa‐let‐7e‐5p in hUC‐MSC‐EVs could protect the oral mucosa from OM by repressing TAB2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsStomatitisAdaptor Proteins, Signal TransducingMesenchymal Stem CellsExtracellular VesiclesLipopolysaccharidesKeratinocytesHumansAnimalsNF-kappa BSignal TransductionCricetinaeDisease Models, AnimalUmbilical CordMouth MucosaCells, Cultured

Stichwörter der Autor:innen

NF‐κBOral mucositisTAB2extracellular vesicleshUC‐MSChsa‐let‐7e‐5pinflammation

Substanzen

MicroRNAsAdaptor Proteins, Signal TransducingLipopolysaccharidesTAB2 protein, humanNF-kappa Bmirnlet7 microRNA, human

Autor:innen und Institutionen

  • Department of Transfusion, Central Laboratory, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
  • College of Ocean Food and Biological Engineering, Jimei University, Xiamen, China.

ORCID-Profile: Gengxin Hao

Zitieren

APA

Lin, S., Lai, D., Tian, Y., Lai, F., Long, M., Ji, C., & Hao, G. (2024). MicroRNA hsa‐let‐7e‐5p in hUC ‐ MSC ‐ EVs alleviates oral mucositis by targeting TAB2. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13399

Vancouver

Lin S, Lai D, Tian Y, Lai F, Long M, Ji C, et al. MicroRNA hsa‐let‐7e‐5p in hUC ‐ MSC ‐ EVs alleviates oral mucositis by targeting TAB2. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13399

BibTeX
@article{Lin2024,
  author = {Lin, Shuting and Lai, Dong and Tian, Yan and Lai, Fei and Long, Min and Ji, Changfu and Hao, Gengxin},
  title = {MicroRNA hsa‐let‐7e‐5p in hUC ‐ MSC ‐ EVs alleviates oral mucositis by targeting TAB2},
  journal = {Scandinavian Journal of Immunology},
  year = {2024},
  doi = {10.1111/sji.13399}
}
Kostenlos starten →